Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201). (Q36747373)
Jump to navigation
Jump to search
scientific article published on 28 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201). |
scientific article published on 28 February 2013 |
Statements
1 reference
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201). (English)
1 reference
Y-K Kang
1 reference
H-M Chang
1 reference
J H Yook
1 reference
M-H Ryu
1 reference
I Park
1 reference
Y J Min
1 reference
D Y Zang
1 reference
G Y Kim
1 reference
D H Yang
1 reference
S J Jang
1 reference
Y S Park
1 reference
J-L Lee
1 reference
T W Kim
1 reference
S T Oh
1 reference
B K Park
1 reference
H-Y Jung
1 reference
B S Kim
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference